APA (7th ed.) Citation

Michaeli, D., & Michaeli, C. T. (2024). Launch and post-launch prices of injectable cancer drugs in the US: Clinical benefit, innovation, epidemiology, and competition. PharmacoEconomics, 42(1), . https://doi.org/10.1007/s40273-023-01320-4

Chicago Style (17th ed.) Citation

Michaeli, Daniel, and Christoph T. Michaeli. "Launch and Post-launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition." PharmacoEconomics 42, no. 1 (2024). https://doi.org/10.1007/s40273-023-01320-4.

MLA (9th ed.) Citation

Michaeli, Daniel, and Christoph T. Michaeli. "Launch and Post-launch Prices of Injectable Cancer Drugs in the US: Clinical Benefit, Innovation, Epidemiology, and Competition." PharmacoEconomics, vol. 42, no. 1, 2024, https://doi.org/10.1007/s40273-023-01320-4.